Home » Topics » Regulatory » Patents

Patents
RSS

Astellas Pharma discloses dopamine D1 receptor PAMs

Jan. 4, 2017

Adhaere Pharmaceuticals presents anticancer agents

Jan. 4, 2017

Almirall describes JAK inhibitors

Jan. 4, 2017

University of Florida discloses aminoacyl-tRNA synthetase inhibitors

Jan. 4, 2017

Bayer Pharma patents muscarinic acetylcholine M2 receptor PAMs

Jan. 4, 2017

Australian scientists present KAT6A inhibitors

Jan. 3, 2017

Bayer Pharma reports development of anticancer agents

Jan. 3, 2017

Lilly describes MetAP2 inhibitors

Jan. 3, 2017

Almirall discloses PI3K inhibitors

Jan. 3, 2017

Pfizer patents PDE4 inhibitors

Jan. 3, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...